Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral Neuromodulation

Chartier‐Kastler, Emmanuel; Normand, L. Le; Ruffion, A.; Saussine, C.; Braguet, R.; Rabut, Bertrand; Ragni, E.; Perrouin‐Verbe, Marie‐Aimée; Pierrevelcin, Jean; Rousseau, Thierry; Gamé, X.; Tanneau, Yves; Dargent, François; Biardeau, Xavier; Graziana, Jean Pierre; Stoica, Gabriel; Brassart, É.; Fourmarier, M.; Yaghi, Najdat; Capon, G.; Ferchaud, Jérôme; Berrogain, N.; Peyrat, L.; Pecoux, F.; Bryckaert, Pierre-Emmanuel; Karsenty, G.; Song, Shannon; Keller, D. U. J.; Cornu, Jean‐Nicolas

doi:10.1016/j.euf.2023.03.008

Cited by 4 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SNM has been used for refractory OAB ‘dry’ (without urinary incontinence) and ‘wet’ (with urinary incontinence) for more than 2 decades, with success rates of 70–80%, similar to those of intravesical botulinum toxin [ 8 ]. Since the approval of InterStim therapy by European Conformity (CE) (1995) and the Food and Drug Administration (FDA) (1997), SNM has become an established advanced treatment option for OAB, which has treated more than 375,000 patients worldwide [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

Evolving types of pudendal neuromodulation for lower urinary tract dysfunction

2024

Cent Eur J Urol

View full text Add to dashboard Cite

Introduction Sacral neuromodulation and posterior tibial nerve stimulation for lower urinary tract dysfunction (LUTD) and overactive bladder yield good and reliable results. However, neuromodulation research is continuously evolving because there is still need for more patient-friendly treatment options in the therapeutic management of LUTD. Pudendal neuromodulation (PNM) has been emerging as a promising alternative treatment option for the last few decades. The aim of this study is to review the current state of the art of PNM. Material and methods A wide literature search was conducted in the field of PNM using Medline through the PubMed database and Elsevier using the Scopus database; a critical review of the results was then carried out. PNM has been studied in its various possible aspects: percutaneous PNM, transrectal/transvaginal PNM, and both percutaneous and transcutaneous dorsal genital nerve stimulation. Results Each technique was found to result in promising improvements in different clinical outcomes, with some trials reporting even better results than sacral neuromodulation. Conclusions As a result of a comparison between the various PNM techniques with both sacral neuromodulation and posterior tibial nerve stimulation, we think that PNM should be seen as seriously promising, and we believe it will expand the treatment options for overactive bladder. Even though several studies accordingly showed PNM to be safe and effective, a systematic review and meta-analysis were not feasible. PNM in its various techniques is a promising treatment for LUTD. Nevertheless, further research is needed to include it in treatment algorithms.

show abstract

Section: Introductionmentioning

confidence: 99%

Evolving types of pudendal neuromodulation for lower urinary tract dysfunction

2024

Cent Eur J Urol

View full text Add to dashboard Cite

show abstract

“…Although these results may appear satisfactory, two major limitations need to be highlighted: the rate of "cured" patients, as well as "real life" long-term follow-up and efficacy. Regarding the rate of patients who are truly "cured", among patients with UUI at the time of the test phase, only 25% to 36% regained full continence at 3 months, and among these patients, only 33% to 45% were still continent at 5 years (124). So, even though sacral neuromodulation appears to be the only therapy that can be maintained over time -compared to all other second-and third-line therapies -the fact remains that it only "cures" a minority of patients.…”

Section: Iv2d Efficacy Of Sacral Neuromodulationmentioning

confidence: 99%